drugset / Trial / NCT00004151

Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00004151 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of acridine carboxamide in treating patients who have advanced non-small cell lung cancer that cannot be treated with surgery.

Timeline

Start
1999-09
Primary completion
2000-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject acridine carboxamide Unknown — Intravenous

Indications